Top 10 landmark studies in hypertension

Journal of the American Society of Hypertension

Volumn 8, Issue 6, 2014, Pages 437-447

  Edwards, Elizabeth W ^a   Dipette, Donald J ^a   Townsend, Raymond R ^b   Cohen, Debbie L ^b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Blood pressure; clinical trials

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENAZEPRIL; CAPTOPRIL; CHLORTALIDONE; CLONIDINE; DOXAZOSIN; ENALAPRIL; FELODIPINE; FUROSEMIDE; GUANETHIDINE; HYDRALAZINE; LISINOPRIL; METHYLDOPA; MINOXIDIL; NITRENDIPINE; RESERPINE; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CLINICAL TRIAL (TOPIC); DISEASE MANAGEMENT; PATHOPHYSIOLOGY; PROCEDURES;

BLOOD PRESSURE; CLINICAL TRIALS AS TOPIC; DISEASE MANAGEMENT; HUMANS; HYPERTENSION;

EID: 84903118390     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2014.03.333     Document Type: Review

References (22)

1. G. Mancia Blood pressure reduction and cardiovascular outcomes: past, present, and future Am J Cardiol 100 2007 4 9
2. The Edward D. Freis Papers - Profiles in Science, National Library of Medicine. Early Career and Work with Antihypertensive Drugs, 1940-1949.
3. S.S. Yoon, V. Burt, T. Louis, and M.D. Carroll Hypertension among adults in the United States, 2009-2010 NCHS Data Brief 2012 1 8
4. P. Yoon, C. Gillespie, M. George, and H. Wall Control of hypertension among adults - National Health and Nutrition Examination Survey, United States, 2005-2008 MMWR Morb Mortal Wkly Rep 61 2012 19 25
5. T.A. Farley, M.A. Dalal, F. Mostashari, and T.R. Frieden Deaths preventable in the U.S. by improvements in use of clinical preventive services Am J Prev Med 38 2010 600 609
6. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
7. Veterans Administration Cooperative Study Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mm Hg JAMA 202 1967 116 122
8. Veterans Administration Cooperative Study Effects of treatment on morbidity in hypertension II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg JAMA 213 1970 1143 1152
9. Veterans Administration Cooperative Study Effects of treatment on morbidity in hypertension: influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects Circ 45 1972 991 1004
10. Hypertension Detection and Follow-up Program Cooperative Group Five-year findings of the hypertension detection and follow-up program. Reduction in mortality of persons with high blood pressure, including mild hypertension JAMA 242 1979 2562 2571
11. Hypertension Detection and Follow-up Program Cooperative Group Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. JAMA 242 1979 2572 2577
12. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 1991 3255 3264
13. J.A. Staessen, R. Fagard, L. Thijs, H. Celis, G.G. Arabidze, and W.H. Birkenhager et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators Lancet 350 1997 757 764
14. L. Hansson, A. Zanchetti, S.G. Carruthers, B. Dahlof, D. Elmfeldt, and S. Julius et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet 351 1998 1755 1762
15. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
16. K. Jamerson, M.A. Weber, G.L. Bakris, B. Dahlof, B. Pitt, and V. Shi et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2008 2417 2428
17. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 1998 703 713
18. W.C. Cushman, G.W. Evans, R.P. Byington, D.C. Goff Jr., R.H. Grimm Jr., and J.A. Cutler et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
19. L.A. Hebert, J.W. Kusek, T. Greene, L.Y. Agodoa, C.A. Jones, and A.S. Levey et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group Hypertension 30 3 Pt 1 1997 428 435
20. J.T. Wright Jr., L. Agodoa, G. Contreras, T. Greene, J.G. Douglas, and J. Lash et al. Successful blood pressure control in the African American Study of Kidney Disease and Hypertension Arch Intern Med 162 2002 1636 1643
21. M.A. Weber, K. Jamerson, G.L. Bakris, M.R. Weir, D. Zappe, and Y. Zhang et al. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomized controlled trial Lancet 381 2013 537 545
22. P. King, I. Peacock, and R. Donnelly The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes Br J Clin Pharmacol 48 1999 643 648